ACGN Aceragen
- 0.385
- 0.0000.00%
Aceragen News
Aceragen (ACGN.US) directors sold 51 common shares worth approximately $26.01
It was reported on August 12 that according to documents disclosed by the US Securities and Exchange Commission (SEC) on August 11, $Aceragen (ACGN.US) $ director GOWEN MAXINE sold 51 common shares at an average price of 0.51 US dollars per share on August 10, with a value of about 26.01 US dollars. Image source: SEC's official website What is a statement on changes in shareholding? The SEC requires insiders of listed companies to publicly disclose their securities transactions and shareholding information. When an insider's shareholding changes, depending on the circumstances, it is necessary to file with the SEC within a certain period of time after the transaction ends
Aceragen (ACGN.US) directors sold 3,283 common shares worth approximately $1,750.17
On August 12, it was reported that according to documents disclosed by the US Securities and Exchange Commission (SEC) on August 11, $Aceragen (ACGN.US) $ director MILANO VINCENT sold 3,283 common shares at an average price of 0.5331 US dollars per share on August 10, with a value of about 1,750.17 US dollars. Image source: SEC's official website What is a statement on changes in shareholding? The SEC requires insiders of listed companies to publicly disclose their securities transactions and shareholding information. When an insider's shareholding changes, depending on the circumstances, it is necessary to do so after the transaction is completed
12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Monday's Intraday Session
Why Aceragen (ACGN) Stock Is Down 30% Today
12 Health Care Stocks Moving In Friday's After-Market Session
Aceragen, Inc. to Delist From The Nasdaq Stock Market
U.S. Shares Mixed at Close of Trade; Dow Jones Industrial Average up 0.23%
Stocks That Hit 52-Week Lows On Wednesday
Stocks That Hit 52-Week Lows On Tuesday
12 Health Care Stocks Moving In Friday's Intraday Session
XXII, GP and ACGN Among Mid-day Movers
Stocks That Hit 52-Week Lows On Thursday
Aceragen (ACGN.US) shareholders increased their common stock holdings by 27,000 shares, worth approximately US$383,000
It was reported on July 20 that according to documents disclosed by the US Securities and Exchange Commission (SEC) on July 19, $Aceragen (ACGN.US) $ shareholder Pillar Invest Corp increased 27,000 common shares at an average price of 1.42 US dollars per share on May 17, with a value of about 38,300 US dollars; on July 12 and 13, it sold 5,818 common shares at an average price of 1.56 US dollars per share, with a value of about 9,103.92 US dollars. This transaction involves another related party: Pillar Partners Found
Aceragen Receives Non-Compliance Notice From Nasdaq
Aceragen Receives Non-compliance Notice From Nasdaq
Aceragen, Inc. Receives Nasdaq Notice Regarding Delayed Form 10-Q Filing
Insider Sell: Aceragen
Immuron, ANI Pharmaceuticals Top Healthcare Gainers; Catalent, Aptorum Among Losers
Aceragen On April 28, 2023, The Board Of Directors Of Aceragen, Inc. Approved A Reduction In Workforce Of Approximately 80%, Effective Immediately, As Part Of Previously Disclosed Cost-Cutting Measures.
Analysis
Price Target
No Data
No Data